Mounjaro®
Starting from £179.99/mo
Start journey Learn moreOmeprazole and semaglutide can generally be taken together, and the combination is common in clinical practice. Omeprazole is a proton pump inhibitor (PPI) used to reduce stomach acid; semaglutide is a GLP-1 receptor agonist that supports weight loss. Because semaglutide slows how quickly the stomach empties its contents, questions about how it affects the absorption and timing of other medicines — omeprazole included — are reasonable ones. This page sets out what is currently known, what remains uncertain, and what to discuss with your prescriber before making any decision about your medicines. These are prescription-only medicines, and any changes to how or when you take them should be agreed with a clinician, not made independently.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the decision most people are quietly trying to make: should I stop omeprazole, change when I take it, or carry on as usual once I start semaglutide?
The mechanism behind the concern is straightforward. Semaglutide reduces the speed of gastric emptying, meaning food and medicines spend longer in the stomach before moving into the small intestine where absorption mostly happens. For medicines with narrow therapeutic windows or steep dose-response curves, even a modest delay can matter. Omeprazole sits in a different category. It is an enteric-coated tablet or capsule designed to pass through the stomach intact and dissolve in the small intestine regardless, partly because it degrades in acid. The extra dwell time in the stomach caused by semaglutide is therefore less likely to disrupt it than it might disrupt an immediate-release tablet.
Novo Nordisk's clinical pharmacology work, referenced in the semaglutide prescribing documentation, assessed several co-administered drugs including omeprazole and found no clinically significant change in overall exposure (area under the curve) at steady state. The NHS semaglutide medicines page notes that the interaction profile of semaglutide with other oral drugs should be considered, without flagging omeprazole as a specific high-risk pairing. That is reassuring, but it is not a blanket clearance: individual responses vary, and some people do notice changes in symptom pattern when starting semaglutide.
There is a common misconception worth gently setting aside: that PPIs and GLP-1 medicines somehow cancel each other out or work against each other. They do not. They act on completely different pathways. The only real overlap is the GI symptom landscape, and that is manageable with the right clinical support. If you are also taking antibiotics alongside your treatment, our page on how metronidazole and semaglutide interact covers that combination in detail.
Nausea, bloating, reflux and indigestion appear on both medicines' side-effect profiles, which creates a practical diagnostic puzzle. If you start semaglutide while already taking omeprazole and notice new or worsening gut symptoms, it is not always obvious which medicine is contributing, or whether the combination is.
Semaglutide's gastrointestinal effects are well-characterised: they tend to be most noticeable in the first few weeks of treatment or after a dose increase, then settle for most people. The NHS guidance on semaglutide lists nausea, vomiting, diarrhoea and constipation as common effects, typically mild to moderate. Omeprazole, at its standard doses, causes GI side effects in a smaller proportion of users, headache and diarrhoea are among the more frequently reported.
If symptoms are significant or persistent, the right move is to tell your prescriber rather than adjust either medicine yourself. Stopping omeprazole abruptly can cause rebound acid, which is uncomfortable and may confuse the picture further. Equally, slowing your semaglutide titration (if that is what the symptoms suggest) is a clinical decision, not one to make from a symptom tracker alone. Keeping a simple symptom diary for the first four to six weeks of semaglutide is something many people find useful; it gives your prescriber something concrete to work from.
For broader context on how semaglutide is processed in the body, our page on how semaglutide is metabolised explains the pharmacokinetic pathway in plain terms.
Omeprazole is most effective when taken 30 to 60 minutes before a meal, particularly breakfast. That recommendation exists because proton pump inhibitors need active acid-secreting pumps to work, and eating stimulates those pumps. Semaglutide is a once-weekly subcutaneous injection taken on any consistent day of the week, independent of food. The two timings do not conflict in any mechanistic sense.
Where things get slightly more nuanced is with the oral form of semaglutide (Wegovy tablets) which carries strict absorption rules of its own: taken first thing on an empty stomach with a small amount of plain water, with a 30-minute wait before anything else, including other oral medicines. If you use the Wegovy tablet and take omeprazole in the morning, you would typically take your semaglutide tablet first, wait the required 30 minutes, then take omeprazole before breakfast. Your prescriber or pharmacist can confirm the right sequence for your routine. More about the Wegovy injection and how it is used is on our Wegovy page.
The weekly injection form carries no such morning timing restriction, so omeprazole can be taken at whatever time your prescriber has recommended, without reference to the injection day. Practically, most people on the injection simply carry on their existing omeprazole habit unchanged, which is usually appropriate. If you are unsure, check our frequently asked questions or speak directly with the clinical team.
If you take omeprazole regularly (whether for gastro-oesophageal reflux, a peptic ulcer, or as a stomach-protective measure alongside other medicines) your prescriber needs to know. This is not because the combination is typically problematic; it is because a complete medicine list allows the prescriber to look at your overall picture accurately.
At a semaglutide consultation through a service like nume, your prescriber will review your health background, current medicines and symptoms before confirming suitability. Relevant questions include whether your reflux has been well-controlled recently (semaglutide can temporarily worsen it in some people) and whether there are any dose-dependent reasons your omeprazole might need revisiting. For a detailed look at the 1 mg dose specifically, our semaglutide 1 mg page covers what to expect at that stage of treatment. If you are considering a formal step toward treatment, you can also explore the weight-loss treatment options we offer before deciding.
People already established on semaglutide who are newly prescribed omeprazole should apply the same principle in reverse: tell the prescribing doctor or pharmacist about the semaglutide. It is a simple step that prevents assumptions on both sides. Some people also want to understand whether semaglutide affects other aspects of their health, and our page on semaglutide and erectile dysfunction addresses one question that comes up more often than you might expect.
If you have questions that go beyond what a page like this can address, speaking to a prescriber directly is always the better path. You can start your free consultation with our clinical team and get a same-day clinical review from a GPhC-registered prescriber who can consider your specific medicine list.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.